Your browser doesn't support javascript.
loading
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101].
Choueiri, T K; Larkin, J; Pal, S; Motzer, R J; Rini, B I; Venugopal, B; Alekseev, B; Miyake, H; Gravis, G; Bilen, M A; Hariharan, S; Chudnovsky, A; Ching, K A; Mu, X J; Mariani, M; Robbins, P B; Huang, B; di Pietro, A; Albiges, L.
Afiliação
  • Choueiri TK; Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu.
  • Larkin J; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
  • Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA.
  • Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Rini BI; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA.
  • Venugopal B; Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.
  • Alekseev B; P. Hertsen Moscow Oncology Research Institute, Moscow, Russia.
  • Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France.
  • Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA.
  • Hariharan S; Oncology, Pfizer, New York, USA.
  • Chudnovsky A; Oncology, Pfizer, Cambridge, USA.
  • Ching KA; Computational Biology, Pfizer, San Diego, USA.
  • Mu XJ; Computational Biology, Pfizer, San Diego, USA.
  • Mariani M; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy.
  • Robbins PB; Translational Oncology, Pfizer, San Diego, USA.
  • Huang B; Biostatistics, Pfizer, Groton, USA.
  • di Pietro A; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy.
  • Albiges L; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
ESMO Open ; 6(4): 100177, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34474809
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article